Table 2. Study sites distribution, demographic characteristics, and main underlying diseases among the study subjects.
| Frequency (N) | Percent (%) | |
|---|---|---|
| Study site (s) | ||
| Hospital 1 | 195 | 12.2 |
| Hospital 2 | 198 | 12.4 |
| Hospital 1* | 191 | 12.0 |
| Hospital 2* | 198 | 12.4 |
| PCC 1 | 104 | 6.6 |
| PCC 2 | 99 | 6.2 |
| PCC 3 | 100 | 6.2 |
| PCC 4 | 101 | 6.3 |
| PCC 1* | 100 | 6.2 |
| PCC 2* | 100 | 6.2 |
| PCC 3* | 108 | 6.8 |
| PCC 4* | 104 | 6.5 |
| Gender | ||
| Male | 693 | 43.4 |
| Female | 905 | 56.6 |
| Race | ||
| Malay | 1,350 | 84.5 |
| Chinese | 141 | 8.8 |
| Indian | 94 | 5.9 |
| Others | 13 | 0.8 |
| ASCVD | ||
| Yes | 361 | 22.6 |
| No | 1,237 | 77.4 |
| Hypertension | ||
| Hypertensive | 1309 | 82 |
| Not Hypertensive | 289 | 18 |
| Dyslipidaemia | ||
| Yes | 465 | 29 |
| No | 1,133 | 71 |
| Total | 1,598 | 100.0 |
Note: * refer to data related to the post-intervention phase.